Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
Hamideh Parhiz(University of Pennsylvania), Jacob S. Brenner(Translational Therapeutics (United States)), Priyal Patel(Translational Therapeutics (United States)), Tyler E. Papp(University of Pennsylvania), Hamna Shahnawaz(University of Pennsylvania), Qin Li(University of Pennsylvania), Ruiqi Shi(University of Pennsylvania), Marco E. Zamora(Translational Therapeutics (United States)), Amir Yadegari(University of Pennsylvania), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Ambika Natesan(University of Pennsylvania), Norbert Pardi(University of Pennsylvania), Vladimir V. Shuvaev(Translational Therapeutics (United States)), Raisa Y. Kiseleva(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Thomas Uhler(Translational Therapeutics (United States)), Rachel Riley(University of Pennsylvania), Xuexiang Han(University of Pennsylvania), Michael J. Mitchell(California Institute for Regenerative Medicine), Kieu Lam, James Heyes, Drew Weissman(University of Pennsylvania), Vladimir R. Muzykantov(Translational Therapeutics (United States))
Cited by 141Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis